Phosphate homeostasis, monitoring and managment of hyperphosphatemia in patients with the Chronic Kidney diseases

Site: ISM-PHD
Course: Clinical Nutrition practice in chronic kidney diseases
Book: Phosphate homeostasis, monitoring and managment of hyperphosphatemia in patients with the Chronic Kidney diseases
Printed by: Guest user
Date: Tuesday, 19 May 2026, 12:14 PM

Description

This section presents material on the significance of hyperphosphatemia in patients with CKD, Dietary Therapy for Managing Hyperphosphatemia

1. Phosphate homeostasis

Phosphate is an abundant mineral found in the body. The body store of phosphate is 500 to 800 g, with 85% of the total body phosphate present in crystals of hydroxyapatite in the bone — about 10%  found in muscles and bones in association with proteins, carbohydrates, and lipids. The rest gets distributed in various compounds in the extracellular fluid (ECF) and intracellular fluid (ICF). Phosphate is predominantly an intracellular anion.

The normal plasma inorganic phosphate (Pi ) concentration in an adult is 2.5 to 4.5 mg/dl, and men have a slightly higher concentration than women. In children, the normal range is 4 to 7 mg/dl. A plasma phosphate level higher than 4.5 mg/dL is hyperphosphatemia. 

It is possible to achieve normal levels of phosphorus in the blood of patients on dialysis only in 40-50%.

             Figure. Serum phosphorus of patients on dialysis (USA)

Serum phosphorus

Phosphate plays an essential role in many biological functions such as the formation of ATP, cyclic AMP, phosphorylation of proteins, etc. Phosphate is also present in nucleic acids and acts as an important intracellular buffer.

Normal adult dietary phosphate intake is around 1000 mg/day. 90% of this is absorbed primarily in the jejunum. In the small intestine, phosphate is absorbed both actively and by passive paracellular diffusion. Active absorption is through sodium-dependent phosphate co-transporter type IIb (NPT2b).

      Figure. Transepithelial phosphate transport in the small intestine.

 Transepithelial phosphate transport in the small intestin

(Phosphate enters the enterocyte (influx) through the brush border membrane using the Na+ /Pi cotransport system, with a stoichiometry of 2 : 1, operating against an electrochemical gradient. Phosphate exit at the basolateral side possibly occurs by passive diffusion or more probably by anion exchange)


Kidneys excrete ninety percent of the daily phosphate load while the gastrointestinal tract excretes the remainder (Figure). 

Phosphorus homeostasis in healthy adults

   Figure - Phosphorus homeostasis in healthy adults (Dr. David St-Jules., 2022)

As phosphorus is not significantly bound to albumin, most of it gets filtered at the glomerulus. Therefore, the number of functional nephrons plays a significant role in phosphorus homeostasis; 75% of filtered phosphorus is reabsorbed in the proximal tubule, approximately 10% in the distal tubule, and 15% is lost in the urine. In the luminal side of the proximal tubule, the primary phosphorus transporter is the Type II Na/Pi co-transporter (NPT-2a). The activity of this transporter is increased by low serum phosphorus and 1,25(OH)2 vitamin D, increasing reabsorption of phosphorus. Renal tubular phosphorus reabsorption also increases by volume depletion, chronic hypocalcemia, metabolic alkalosis, insulin, estrogen, thyroid hormone, and growth hormone.  Tubular reabsorption of phosphorus decreases by parathyroid hormone, phosphatonins, acidosis, hyperphosphatemia, chronic hypercalcemia, and volume expansion.

Phosphorus is transported out of the renal cell by a phosphate-anion exchanger located in the basolateral membrane.

Phosphate homeostasis is under direct hormonal influence of calcitriol, PTH, and phosphatonins, including fibroblast growth factor 23 (FGF-23). Receptors for vitamin D, FGF-23, PTH, and calcium-sensing receptor (CaSR) also play an important role in phosphate homeostasis. Serum phosphate level is maintained through a complex interaction between intestinal phosphate absorption, renal phosphate handling, and the transcellular movement of phosphate that occurs between intracellular fluid and bone storage pool. A transient shift of phosphate into the cells is also stimulated by insulin and respiratory alkalosis.


Richard J. Johnson & John Feehally & Jurgen Floege & Marcello Tonelli.  Comprehensive Clinical Nephrology. Elsevier, Edinburgh, 2019

Dr. David St-Jules. A Systematic Review of Online Resources on Dietary Management of Hyperphosphatemia in People with Chronic Kidney Disease (CKD). University of Nevada, Reno. December,2022



2. Sodium-dependent Pi co-transporters

Absorption of phosphate is mediated by the brush border sodium-dependent Pi co-transporters (NPT), which depend on the Na/K-dependent ATPase. There are three classes of these co-transporters.


Richard J. Johnson & John Feehally & Jurgen Floege & Marcello Tonelli.  Comprehensive Clinical Nephrology. Elsevier, Edinburgh, 2019

3. Parathyroid hormone (PTH)

Parathyroid hormone (PTH) is an important hormone that controls calcium and phosphate concentration through stimulation of renal tubular calcium reabsorption and bone resorption. PTH also stimulates the conversion of 25- hydroxyvitamin D to 1,25 dihydroxy vitamin D in renal tubular cells, which promotes intestinal calcium absorption as well as bone turnover. 

Parathyroid hormone is synthesized, processed, and stored in parathyroid cells. Parathyroid hormone is secreted by exocytosis within seconds after induction of hypocalcemia. In circulation, parathyroid hormone is rapidly taken up by the liver and kidney, where it is cleaved into active amino- and inactive carboxyl-terminal fragments that are then cleared by the kidney. Intact parathyroid hormone has a plasma half-life of two to four minutes.

Any change in ionized calcium concentration gets sensed by calcium-sensing receptor (CaSR) on the surface of parathyroid cells, Increase in calcium activates these receptors, which inhibit parathyroid hormone secretion and decreases renal tubular reabsorption of calcium through second messengers.

Hypocalcemia, induced by increased phosphate levels, can also produce these effects. However, changes in phosphate concentration should be significant to produce substantial changes in serum calcium.  Hyperphosphatemia can also directly stimulate parathyroid hormone synthesis as well as parathyroid cellular proliferation.

      Figure. Role of phosphate retention in the pathogenesis of secondary hyperparathyroidism

Phosphate Retention and Secondary Hyperparathyroidism

(Hyperphosphatemia stimulates parathyroid hormone (PTH) secretion indirectly by inducing hypocalcemia, skeletal resistance to PTH, low levels of calcitriol, and calcitriol resistance. Hyperphosphatemia also has direct effects on the parathyroid gland to increase PTH secretion and parathyroid cell growth. eGFR, Estimated glomerular filtration rate)

Several drugs, such as penicillin, corticosteroids, some diuretics, furosemide, and thiazides, can induce hyperphosphatemia as an adverse reaction.


Richard J. Johnson & John Feehally & Jurgen Floege & Marcello Tonelli.  Comprehensive Clinical Nephrology. Elsevier, Edinburgh, 2019

4. 1, 25 dihydroxycholecalciferol (1, 25 DHCC)

1, 25 dihydroxycholecalciferol is the activated form of Vitamin D. It increases intestinal phosphate absorption by enhancing the expression of NPT2b transporter and stimulates renal phosphate absorption by increasing expression of NPT2a and NPT2c in the proximal tubule. 1,25 DHCC also enhances FGF23 production. The 1,25(OH)2D also suppresses the synthesis of PTH and enhances FGF23 production. 

   Figure. Mechanisms contributing to decreased levels of calcitriol in chronic kidney disease

Mechanisms contributing to decreased levels of calcitriol in chronic kidney disease

(C-PTH, Carboxyl-terminal parathyroid hormone; FGF-23, fibroblast growth factor-23; GFR, glomerular filtration rate; Pi, inorganic phosphate)


Richard J. Johnson & John Feehally & Jurgen Floege & Marcello Tonelli.  Comprehensive Clinical Nephrology. Elsevier, Edinburgh, 2019

5. Fibroblast growth factor 23 (FGF23)

FGF23 is a phosphatonin that is produced primarily by osteocytes and to a lesser extent, by osteoblasts. It is a hormone that consists of 251 amino acid residues, including a signal peptide comprising 24 amino acids.

It inhibits renal tubular reabsorption of phosphate. FGF23 exerts its effects by binding to the FGFR1-Klotho complex. Alpha Klotho serves as a co-receptor. FGF23 suppresses NPT2a and NPT2c expression at the proximal renal tubules, thereby inhibiting renal phosphate reabsorption.FGF23 also reduces the circulatory level of 1,25(OH)2D by decreasing the expression of 1-alpha-hydroxylase and increasing the expression of 24-hydroxylase.


Richard J. Johnson & John Feehally & Jurgen Floege & Marcello Tonelli.  Comprehensive Clinical Nephrology. Elsevier, Edinburgh, 2019

6. Monitoring

As per KDIGO guidelines, serum phosphate, along with calcium, intact parathyroid hormone (iPTH), and 25-hydroxyvitamin D levels are estimated in all patients with an estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m^2.

If the estimated glomerular filtration rate (eGFR) is between 30 to 59 mL/min/1.73 m^2, serum phosphate, and calcium should be measured every 6 to 12 months. In patients with estimated eGFR 15 to 29 mL/min/1.73 m^2, serum phosphate and calcium require assessment every three to six months


Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, Fouque D, Friedman AN, Ghaddar S, Goldstein-Fuchs DJ, Kaysen GA, Kopple JD, Teta D, Yee-Moon Wang A, Cuppari L: KDOQI clinical practice guideline for nutrition in CKD: 2020 update [published correction appears in Am J Kidney Dis S0272-6386(20): 31125–2, 2020 10.1053/j.ajkd.2020.11.004]. Am J Kidney Dis 76[Suppl 1]: S1–S107, 2020

7. Treatment / Management

      Improving Global Outcomes (KDIGO) guidelines for the management of hyperphosphatemia suggest that, in dialysis patients, phosphate levels require lowering toward the normal range; however, there is no given specific target level. In chronic kidney disease patients not receiving dialysis, serum phosphate levels require maintenance in the normal range (i.e., under 4.5 mg/dL [1.45 mmol/L]) (Ikizler TA). 

Dietary interventions, including routine dietary assessment, dietary phosphate restriction, education on reading food labels, and meal preparation with demineralization methods, are core components of hyperphosphatemia management (Figure)



The cornerstones of hyperphosphatemia management in hemodialysis patients include dietary interventions, dialytic removal, and pharmacotherapies. Core components of tailored dietary therapy in hemodialysis patients include routine nutritional assessment and dietary counseling administered by dietitians. BMI, body mass index; Ca, Calcium; GI, gastrointestinal; IBW, ideal body weight; ISRNM, International Society of Renal Nutrition and Metabolism; K, potassium; MIS, malnutrition-inflammation score; Na, sodium; P, phosphate; PTH, parathyroid hormone; PEW, protein energy wasting; PROs, patient-reported outcomes; QOL, quality of life; SGA, subjective global assessment (Narasaki Y).


Acute hyperphosphatemia

If renal function is good, renal phosphate excretion can increase through extracellular volume expansion by saline infusion and diuretics.


Bibliography
Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, Fouque D, Friedman AN, Ghaddar S, Goldstein-Fuchs DJ, Kaysen GA, Kopple JD, Teta D, Yee-Moon Wang A, Cuppari L: KDOQI clinical practice guideline for nutrition in CKD: 2020 update [published correction appears in Am J Kidney Dis S0272-6386(20): 31125–2, 2020 10.1053/j.ajkd.2020.11.004]. Am J Kidney Dis 76[Suppl 1]: S1–S107, 2020
Narasaki Y, Rhee CM. Dietary Therapy for Managing Hyperphosphatemia. Clin J Am Soc Nephrol. 2020 Dec 31;16(1):9-11. doi: 10.2215/CJN.18171120. PMID: 33380472; PMCID: PMC7792640.

7.1. Dietary strategies for limiting phosphorus intake

Choose low phosphorus products and using phosphorus-to-protein ratio <10-12 mg/g

Higher serum phosphate concentrations are associated with mortality, and experimental data suggest that serum phosphate concentration is directly related to bone disease, vascular calcification and cardiovascular disease. Low-phosphorus diets and binders are used to help lower serum phosphate to reduce the long-term complications of CKD-MBD, although more research is needed to fully understand the disease-modifying impact of these interventions

There are actually 3 major sources of phosphates: natural phosphates (as cellular and protein constituents) contained in raw or unprocessed foods, phosphates added to foods during processing, and phosphates in dietary supplements/medications

In adults with CKD 3–5D, it is recommended to adjust dietary phosphorus intake to maintain serum phosphate levels within normal limits. In adults with CKD 1-5D or posttransplantation, it is reasonable when making decisions about phosphorus restriction treatment to consider the bioavailability of phosphorus sources (eg, animal, vegetable, additives). For adults with CKD posttransplantation with hypophosphatemia, it is reasonable to consider prescribing high-phosphorus intake (diet or supplements) in order to replete serum phosphate.

There are physiologic adaptations in the early stages of CKD that prevent excessive phosphorus retention, so the inability to increase phosphorus excretion to avoid phosphorus accumulation and hyperphosphatemia is generally seen when eGFR decreases to <45 mL/min,  being less common in earlier CKD stages. In the setting of anuria in patients receiving maintenance dialysis, hyperphosphatemia risks are particularly heightened, with a prevalence as high as 50%. CKD-specific recommendations suggest maintaining phosphorus intake between 800 and 1,000 mg/d in patients with CKD stages 3-5 and those receiving maintenance dialysis to maintain serum phosphate levels in the normal range

It is recommended to choose natural foods that are low in organic phosphorus over high in protein. The organic phosphorus content per gram of protein varies widely among different foods. Nutrient composition tables, which provide phosphorus to protein ratios, can be used to recommend meal replacement products that can significantly reduce daily organic phosphorus intake while ensuring adequate dietary protein intake

Below are tables with phosphorus content (g/mg) and phosphorus-to protein ratio (mg/g) in various foods and drinks

Table 1- Dietary P, protein, and potassium content of selected food items, ranked according to the P-to-protein ratio categories (Kalantar-Zadeh, Kamyar, 2010)


Substantial amounts of phosphoric acid are usually present in most colas and many other beverages.Many but not all clear-colored soft drinks or teas are low in P;however, most of these drinks contain little to no protein or other organic compounds, and the P is almost exclusively from additives. Being in liquid form, the inorganic P in these drinks are perhaps even more readily absorbable (Table 2). 

Table 2- P content of selected beverages, mostly as a result of additives (based on 12-oz serving) (Kalantar-Zadeh, Kamyar, 2010)

 

Table 3 illustrates variations in P content across diverse types of cheese in German-speaking regions of Europe. The quantity of P in a 50-g portion of cheese varies from <100 mg in Brie cheese to almost half a gram in processed soft cheese, which contains a significant amount of P salt.

 Table 3- Selected types of cheese consumed in German-speaking regions of Europe (Kalantar-Zadeh, Kamyar, 2010)


Table 4- Phosphorus/protein ratio per 100g of food (Barril-Cuadrado G, 2013)


In article provides tables of Phosphorus/protein ratio per 100g of uncooked food from organic animal and plant sources https://www.revistanefrologia.com/en-table-showing-dietary-phosphorus-protein-ratio-articulo-X2013251413003197

Table 5-  Phosphorus and Potassium Content of Commonly Consumed Beverages (Erica Wickham, 2014)
Table Phosphorus and Potassium Content of Commonly Consumed Beverages
Phosphorus and Potassium Content of Commonly Consumed Beverages

Table Phosphorus and Potassium Content of Commonly Consumed Beverages

Table 6- Phosphorus Content of Foods According to Food Group (St-Jules DE, 2017

Food Serving Size 

Phosphorus (mg)


 

Per Serving Per 100 kcal
 
Protein foods 
Chicken breast, roasted, skin removed  3 oz 194 139 
Chicken breast, roasted 3 oz 182 109 
Chicken breast, fried with batter 3 oz 157 71 
Ground beef, 93% lean 3 oz 167 103 
Ground beef, 70% lean 3 oz 141 69 
Eggs 2 large 197 138 
Black beans 1 cup 241 106 
Peanut butter, creamy 2 Tbsp 107 56 
Sesame seeds 1 oz 181 113 
Dairy products 
Milk, skim 1 cup 247 298 
Milk, whole 1 cup 205 138 
Yogurt, low-fat, plain 1 cup 353 229 
Yogurt, low-fat, vanilla 1 cup 331 159 
Cheddar cheese 1.5 oz 193 112 
Vanilla ice cream 1 cup 139 51 
Grains 
Bread, white 1 slice 24 36 
Bread, whole wheat 1 slice 68 84 
Rice, brown 1 cup 208 84 
Rice, white 1 cup 68 33 
Cereal, Kellogg’s Corn Flakes 1 cup 29 29 
Cereal, Kellogg’s All-Bran 1 cup 356 445 
Bran muffin 1 medium 425 139 
Croissant 1 medium 60 26 
Fruits 
Apples 1 cup 12 21 
Applesauce, sweetened 1 cup 18 
Peaches 1 cup 31 52 
Peaches, canned in juice 1 cup 42 38 
Peaches, canned in heavy syrup 1 cup 29 15 
Vegetables 
Carrots 1 cup 45 87 
Broccoli 1 cup 60 194 
Tomatoes 1 cup 43 134 
Tomatoes, canned 1 cup 77 100 
Tomatoes, canned, stewed 1 cup 51 77 
Potatoes 1 medium 123 73 
Potatoes, mashed 1 cup 101 43 
Potatoes, French fries, McDonald’s 1 medium 149 39

Table 7- PHOSPHORUS-TO-PROTEIN RATIO IN USUAL PORTIONS OF FOOD (Pereira, Raíssa & Ramos, 2020)

FoodAmount (g)Usual portionPhosphorus (mg)Protein (g)Ratio phosphorus/protein (mg/g)
Meat and eggs
Chicken801 medium breast fillet15023.06.5
Pork801 medium pork chop14721.26.9
Beef851 medium steak20926.08.0
Whitefish841 medium fillet24120.611.7
Beef liver851 medium steak40422.717.8
Sardine341 unit1708.420.2
Whole egg501 unit906.015
Sausages
Sausage*601 unit12613.99.1
Ham*482 medium slices136149.7
Milk and dairy products
Cheese302 thin slices1537.520.4
Requeijão *301 tablespoon1342.946.2
Natural yogurt1201 small cup1596.325.2
UHT milk*1501 glass1404.928.6
Legumes and nuts
Cooked beans1541 medium ladle1336.919.3
Peanuts501 small package2531319.5

An analysis of phosphorus content (mg/100 g edible part) in the various food groups shows that the highest load comes from nuts, hard cheeses, egg yolk, meat, poultry and fish. Reporting the phosphorus content as mg per gram of protein (mg/g protein) is especially useful for identifying which foods supply less phosphorus with the same amount of protein. Based on the relationship between phosphorus and proteins, an upper limit of 12 mg/g is recommended to identify foods with “favorable” phosphorus to protein ratios (10,11).

For clarity of data, a number of countries have developed phosphorus pyramids (D'Alessandro C, 2015).


Figure - The phosphorus pyramid (D'Alessandro C, 2015)

Foods are distributed on six levels on the basis of their phosphorus content, phosphorus to protein ratio and phosphorus bioavailability. Each level has a colored edge (from green to red, through yellow and orange) that corresponds to recommended consumption frequency, which is the highest at the base (unrestricted intake) and the lowest at the top (avoid as much as possible). a) foods with unfavorable phosphorus to protein ratio (>12 mg/g); b) foods with favorable phosphorus to protein ratio (<12 mg/g); c) fruits and vegetables must be used with caution in dialysis patients to avoid excessive potassium load; d) Fats must be limited in overweight/obese patients, to avoid excessive energy intake; e) sugar must be avoided in diabetic or obese patients; f) protein-free products are dedicated to patients not on dialysis therapy and who need protein restriction but a high energy intake.
You can learn more about the phosphorus pyramid by following the link - https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-16-9.
 
Thus, in patients with CKD receiving dialysis, the daily phosphorus intake is up to 1000 mg. In the diet, it is recommended to take foods with sufficient levels of protein and reduced levels of phosphorus. It is recommended to keep PHOSPHORUS-TO-PROTEIN RATIO less than 12 mg/g.

Nutritional counseling sessions should evolve from the simple concept of phosphate restriction to оpportunities of educating the patient on differentiation between organic and inorganic sources of phosphate and avoidance of phosphate additives.

Bibliography:

KDIGO 2023 clinical practice guideline for the evaluation and management of chronic kidney disease. Public review draft july 2023.
Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011; 305: 1119-1127.
Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-17.
London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740.
Liu Z, Su G, Guo X, et al. Dietary interventions for mineral and bone disorder in people with chronic kidney disease. Cochrane Database Syst Rev 2015; 2015: CD010350.
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements (2017) 7, 1–59.
Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, Fouque D, Friedman AN, Ghaddar S, Goldstein-Fuchs DJ, Kaysen GA, Kopple JD, Teta D, Yee-Moon Wang A, Cuppari L. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020 Sep;76(3 Suppl 1):S1-S107. doi: 10.1053/j.ajkd.2020.05.006. 
Kalantar-Zadeh, Kamyar; Gutekunst, Lisa; Mehrotra, Rajnish; Kovesdy, Csaba P.; Bross, Rachelle; Shinaberger, Christian S.; Noori, Nazanin; Hirschberg, Raimund; Benner, Debbie; Nissenson, Allen R.; Kopple, Joel D. Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology5(3):519-530, March 2010.
Barril-Cuadrado G, Puchulu MB, Sánchez-Tomero JA. Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease. Nefrologia. 2013;33(3):362-71. English, Spanish. doi: 10.3265/Nefrologia.pre2013.
Erica Wickham. Phosphorus Content in Commonly Consumed Beverages. Journal of Renal Nutrition, Vol 24, No 1 (January), 2014: pp e1-e4
St-Jules DE, Goldfarb DS, Pompeii ML, Sevick MA. Phosphate Additive Avoidance in Chronic Kidney Disease. Diabetes Spectr. 2017 May;30(2):101-106. doi: 10.2337/ds16-0048. 
Cupisti A, Kalantar-Zadeh K: Management of natural and added dietary phosphorus burden in kidney disease.Semin Nephrol 2013,33(2):180–90. 10.1016/j.semnephrol.2012.12.018
D'Alessandro C, Piccoli GB, Cupisti A. The "phosphorus pyramid": a visual tool for dietary phosphate management in dialysis and CKD patients. BMC Nephrol. 2015 Jan 20;16:9. doi: 10.1186/1471-2369-16-9.
Dr. David St-Jules. A Systematic Review of Online Resources on Dietary Management of Hyperphosphatemia in People with Chronic Kidney Disease (CKD). University of Nevada, Reno. December,2022

Pereira, Raíssa & Ramos, Christiane & Teixeira, Renata & Muniz, Gisselma & Claudino, Gabriele & Cuppari, Lilian. (2020). Diet in Chronic Kidney Disease: an integrated approach to nutritional therapy. Revista da Associação Médica Brasileira. 66. s59-s67. 10.1590/1806-9282.66.s1.59. 

  Phosphorus bioaccessibility

 Organic phosphorus: Organic phosphorus is bound to carbon-containing molecules. This type of phosphorus is present both in animal and plant-based foods but differ considerably in the form. In general, organic phosphorus from animal foods are about 40-60% bioavailable. In plants, phosphorus is mainly present in nuts, seeds, beans, legumes and grains, and fruits and vegetables contain only small amounts of phosphorus.  Unlike animal-based phosphorus, phosphorus in plants foods is mostlyfound in the form of phytic acid or phytate. Generally, plant-based phosphorus is thought to be less bioavailable than animal-based phosphorus (20-40% bioavailability).

Inorganic phosphorus: In contrast to organic phosphorus, inorganic phosphorus is found as free phosphate. Although inorganic phosphorus occurs naturally in food, the major source in the diet is from food additives that are used in a wide range of processed foods. Phosphorus additives serve a variety of useful functions in processed foods such as increasing shelf life, enhancing color and flavor, emulsifying, and acid-base buffering to name a few. Some common sources of phosphorus-containing food additives include dark colas, enhanced meats, frozen meals, cereals, snack bars, processed or spreadable cheeses, instant food products, and refrigerated bakery products. Generally, inorganic phosphorus has higher bioavailability (70%-100% bioavailability) as compared to organic phosphorus present in natural foods, though the exact bioavailability is controversial. Because phosphorus from food additives has higher bioavailability, the contribution of phosphorus from food additives is disproportionately higher than phosphorus naturally present in foods (Figure) (Dr. David St-Jules). 



Phosphorus bioaccessibility qualitative gradient. Foods can be qualitatively classified as having lower phosphorus bioaccessibility (i.e., plant-based foods), moderate phosphorus bioaccessibility (i.e., animal-based foods), and higher phosphorus bioaccessibility (i.e., foods with phosphorus-containing additives). However, within phosphorus bioaccessibility categories there are factors that may limit or enhance phosphorus bioaccessibility that should be considered (K. Kalantar-Zadeh? 2010)

Bibliography:

Dr. David St-Jules. A Systematic Review of Online Resources on Dietary Management of Hyperphosphatemia in People with Chronic Kidney Disease (CKD). University of Nevada, Reno. December,2022
K. Kalantar-Zadeh, L. Gutekunst, R. Mehrotra, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease Clin J Am Soc Nephrol, 5 (2010), pp. 519-530



Phosphatemic Index 

     Another recently studied concept is the phosphatemic index (PI). Similar to the glycemic index, the phosphatemic index measures the effect that foods and meals have on blood phosphorus levels, reflecting phosphorus bioavailability.  Milk and dairy products had high PI values, pork and ham had medium PI values, and soy and tofu had low PI values. However, the phosphatemic index, like the glycemic index, does not account for differences in phosphorus per serving or relative to energy, nor the underlying severity of CKD-MBD. Future studies should assess the phosphatemic index, and potentially the phosphatemic load, in individuals with CKD to determine if it is a useful educational or research tool.

Bibliography:

Y. Narasaki, M. Yamasaki, S. Matsuura, et al. Phosphatemic index is a novel evaluation tool for dietary phosphorus load: a whole-foods approach. J Ren Nutr, 30 (2020), pp. 493-502
Biruete A, Hill Gallant KM, Lloyd L, Meade A, Moe SM, St-Jules DE, Kistler BM. 'Phos'tering a Clear Message: The Evolution of Dietary Phosphorus Management in Chronic Kidney Disease. J Ren Nutr. 2023 Nov;33(6S):S13-S20
Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(4):683-92.


Culinary Techniques for Reducing Phosphorus

     Cooking and processing methods can also influence both the amount and bioaccessibility of phosphorus in foods. For example, soaking has been shown to reduce the amount of phosphorus in foods including legumes, vegetables, cereals, and grains, as well as some animal-based foods (D.B. Vahia de Abreu et.al).  Wet-cooking methods and slicing meat have been shown to reduce phosphorus while maintaining protein content (S. Ando et.al.).
     However, in addition to the quantity of phosphorus present, processing techniques can also influence phosphorus bioaccessibility. In plants, especially cereals and grains, legumes, seeds, and nuts, phosphorus comes largely from phytate. Phytate is mostly indigestible due to the lack of phytase in the small intestine of humans and has limited accessibility due to its likelihood to chelate with other minerals. Processing techniques such as treatment with phytase, soaking, boiling (>140°C) for prolonged periods of time, fermenting, or germinating may increase the release of phosphorus from phytate and increase the proportion of phosphorus containing compounds less likely to chelate, potentially making the remaining phosphorus more bioaccessible for absorption (U. Schlemmer, E. Morris et.al).
      While culinary techniques including food processing are a potential tool to lower the phosphorus load from the diet, there are sparse data in this area, particularly as it relates to phosphorus bioavailability. Some culinary methods may both lower the overall quantity and increase the accessibility of phosphorus.

Bibliography:
D.B. Vahia de Abreu, K. Picard, M.R. Simas Torres Klein, O. Marino Gadas, C. Richard, M.I. Barreto Silva. Soaking to reduce potassium and phosphorus content of foods J Ren Nutr, 33 (2022), pp. 165-171
S. Ando, M. Sakuma, Y. Morimoto, H. Arai. The effect of various boiling conditions on reduction of phosphorus and protein in meat J Ren Nutr, 25 (2015), pp. 504-509
U. Schlemmer, W. Frolich, R.M. Prieto, F. Grases. Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis Mol Nutr Food Res, 53 (Suppl 2) (2009), pp. S330-S375
E. Morris, D. Hill Inositol phosphate content of selected dry beans, peas, and lentils, raw and cooked. J Food Compos Anal, 9 (1996), pp. 2-12
Biruete A, Hill Gallant KM, Lloyd L, Meade A, Moe SM, St-Jules DE, Kistler BM. 'Phos'tering a Clear Message: The Evolution of Dietary Phosphorus Management in Chronic Kidney Disease. J Ren Nutr. 2023 Nov;33(6S):S13-S20

Limiting the use of phosphorus-containing additives

     Phosphorus is the main component of many preservatives and additive salts found in processed foods. When an artificial source of phosphorus is eaten, the body absorbs 90-100% of what’s eaten! Additives are used in food processing for a variety of reasons such as to extend shelf life, improve color, enhance flavor, and retain moisture. Common sources of inorganic phosphorus include certain beverages, enhanced or restructured meats, frozen meals, cereals, snack bars, processed or spreadable cheeses, instant products, and refrigerated bakery products.  Fast food places and many restaurants also serve foods that contain inorganic phosphorus.
Table lists some of the most widely used additives containing phosphorus and the corresponding initials in the European Union countries.

     Table 8. P-containing preservatives most commonly used in the trade and food industry (Cupisti A et al.) 

Initials

Full Name

Food

E 338

Phosphoric acid

Cola and similar; fruit-flavoured soft drinks; jellies

E 339a    

Sodium dihydrogen orthophosphate         

Candid fruit; soft drinks

E 339b

Disodium hydrogen orthophosphate

Processed fruit products

E 339c

Trisodium orthophosphate

Partly dehydrated milk containing at least 28% of dry matter

E 340a

Potassium orthophosphate

Partly dehydrated milk containing more than 28% of dry matter

E 340b

Dipotassium hydrogen orthophosphate

Dehydrated milk and skimmed milk

E 340c

Tripotassium orthophosphate

Dehydrated milk and skimmed milk

E 341a

Calcium tetrahydrogen  diorthophosphate                                  

Soft drinks, cola in particular; jellies

E 341b

Calcium hydrogen orthophosphate

Soft drinks, cola in particular; jellies

E 341c

Tricalcium diorthophosphate

Soft drinks, cola in particular; jellies

E 343

Magnesium phosphate

Fresh cheese, except mozzarella cheese

E 450

Polyphosphates

Bread, matl, toasted barley, coffee, chocolate, processed cheese, ice cream and dessert, potato flour, cooked ham, canned meat, cooked sausages, breaded products

E 540

Calcium diphosphate

Baked products

E 541

Sodium aluminum phosphate

Dehydrated milk, processed egg products, various flours

E 544

Calcium polyphosphates

Sauces, soups and broth, infusions made with instant tea, chewing gum, alcoholic beverages except wine and beer, powdered sugar, frozen fillets of unprocessed fish, spreadable fats (except butter), beverages made from coffee for vending machines, flavours

E 545

Ammonium polyphosphate

Cocoa and products made with chocolate


Table 9. Commonly used phosphorus additives used in the food industry, their purposes and food sources (Dr. David St-Jules) 

.

Table 10- Common phosphate additives used by food industry (Kalantar-Zadeh, 2010)


Most beverages contain little to no protein and, hence, any phosphate content is almost entirely from additives. As a consequence, patients who consume beverages with high phosphate content had serum phosphate levels that are often quite high whereas their nutritional status may be inferior. Additives can contribute more than 30% of the daily dietary phosphorus intake. 
Patients should review food labels to limit intake of foods high in phosphorus. For exemple: Pork Chops (Lean). Pork Fresh Loin Sirloin (Chops) Bone-In Separable Lean Only Cooked Braised, serving saze 170 mg - 6 oz - https://tools.myfooddata.com/nutrition-facts/167838/wt9.  170 grams of this product contains 515 mg of phosphorus. This product contains high levels of phosphorus. 85 mg (3 oz) of this product contains 257 mg of phosphorus, which corresponds to 21% of the recommended intake -https://tools.myfooddata.com/nutrition-facts/167838/wt1/1. 100 grams of this product contains 303 mg of phosphorus or 24% of the recommended intake - https://tools.myfooddata.com/nutrition-facts/167838/100g/1.200 kilocalories (103 g) of this product contain 311 mg of phosphorus - 25% of the recommended intake - https://tools.myfooddata.com/nutrition-facts/167838/200cals/1
Thus, knowing the level of phosphorus, a patient with CKD stage 5 can select foods with low levels of phosphorus.
Patient education is important: creating websites with information, brochures, manuals, infographics.

Examples are given below

advertisement

Conclusion
Dietary intake of P is derived largely from foods with high protein content or food additives and is an important determinant of P balance in patients who have CKD and have a greatly reduced GFR. PO4 additives can dramatically increase the amount of P consumed in the daily diet, especially because P is more readily absorbed in its inorganic form. In contrast, plant foods, including seeds and legumes that are high in P, are usually associated with the least intestinal P absorption because of the phytate in these foods. Hence, the P burden from food additives in fast foods, soft drinks, and processed cheese and snacks is disproportionately high relative to its dietary P content compared with natural P sources from animal and plant protein. In patients with CKD, a mixed composition of dietary animal and plant foods that are rich in phytic acid should be encouraged, whereas the intake of processed foods should be limited.  The increased use of P additives in food, coupled with the increased popularity of convenience foods and frequenting of fast food restaurants, has greatly increased the amount of P consumed by both the general population and patients with CKD. Meals that have lower amounts of organic and particularly inorganic P and are rich in high-value protein, along with P binders, can be provided during long hemodialysis treatment sessions to patients with CKD within inside dialysis clinics and monitored in-center by renal dietitians and nephrologists.  

Bibliography:

KDIGO 2023 clinical practice guideline for the evaluation and management of chronic kidney disease. Public review draft july 2023.
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements (2017) 7, 1–59.
Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, Fouque D, Friedman AN, Ghaddar S, Goldstein-Fuchs DJ, Kaysen GA, Kopple JD, Teta D, Yee-Moon Wang A, Cuppari L. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020 Sep;76(3 Suppl 1):S1-S107. doi: 10.1053/j.ajkd.2020.05.006. 
Kalantar-Zadeh, Kamyar; Gutekunst, Lisa; Mehrotra, Rajnish; Kovesdy, Csaba P.; Bross, Rachelle; Shinaberger, Christian S.; Noori, Nazanin; Hirschberg, Raimund; Benner, Debbie; Nissenson, Allen R.; Kopple, Joel D. Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology5(3):519-530, March 2010.
Cupisti A, Kalantar-Zadeh K: Management of natural and added dietary phosphorus burden in kidney disease.Semin Nephrol 2013,33(2):180–90. 10.1016/j.semnephrol.2012.12.018
D'Alessandro C, Piccoli GB, Cupisti A. The "phosphorus pyramid": a visual tool for dietary phosphate management in dialysis and CKD patients. BMC Nephrol. 2015 Jan 20;16:9. doi: 10.1186/1471-2369-16-9.
Dr. David St-Jules. A Systematic Review of Online Resources on Dietary Management of Hyperphosphatemia in People with Chronic Kidney Disease (CKD). University of Nevada, Reno. December,2022

8. Sourse

  • Goyal R, Jialal I. Hyperphosphatemia. [Updated 2023 Jun 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551586.
  • Richard J. Johnson & John Feehally & Jurgen Floege & Marcello Tonelli.  Comprehensive Clinical Nephrology. Elsevier, Edinburgh, 2019
  • US-DOPPS Practice Monitor. May 2021: https;//www.dops.org/DPM
  • Pereira RA, Ramos CI, Teixeira RR, Muniz GAS, Claudino G, Cuppari L. Diet in Chronic Kidney Disease: an integrated approach to nutritional therapy. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s59-s67. doi: 10.1590/1806-9282.66.S1.59. PMID: 31939537.